Peer Review reports
From: LINC02126 is a potential diagnostic, prognostic and immunotherapeutic target for lung adenocarcinoma
| Original Submission | ||
|---|---|---|
| 14 Sep 2022 | Submitted | Original manuscript |
| 22 Sep 2022 | Reviewed | Reviewer Report - Charuta Agashe |
| 27 Sep 2022 | Reviewed | Reviewer Report |
| 27 Sep 2022 | Reviewed | Reviewer Report |
| 28 Sep 2022 | Reviewed | Reviewer Report |
| 28 Sep 2022 | Reviewed | Reviewer Report |
| 12 Oct 2022 | Author responded | Author comments - Jixian Liu |
| Resubmission - Version 2 | ||
| 12 Oct 2022 | Submitted | Manuscript version 2 |
| 17 Oct 2022 | Author responded | Author comments - Jixian Liu |
| Resubmission - Version 3 | ||
| 17 Oct 2022 | Submitted | Manuscript version 3 |
| 17 Oct 2022 | Author responded | Author comments - Jixian Liu |
| Resubmission - Version 4 | ||
| 17 Oct 2022 | Submitted | Manuscript version 4 |
| 18 Oct 2022 | Reviewed | Reviewer Report |
| 19 Oct 2022 | Reviewed | Reviewer Report |
| 19 Oct 2022 | Reviewed | Reviewer Report |
| 21 Oct 2022 | Reviewed | Reviewer Report |
| 28 Oct 2022 | Reviewed | Reviewer Report - Charuta Agashe |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 2 Nov 2022 | Editorially accepted | |
| 10 Nov 2022 | Article published | 10.1186/s12890-022-02215-4 |
You can find further information about peer review here.